299 related articles for article (PubMed ID: 37628874)
1. Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer.
Abbas Syed R; Davey MG; Richard V; Miller N; Kerin MJ
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628874
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and microRNAs: therapeutic impact.
Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
[TBL] [Abstract][Full Text] [Related]
3. The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.
Davey MG; Davies M; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361056
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer.
Davey MG; Abbas R; Kerin EP; Casey MC; McGuire A; Waldron RM; Heneghan HM; Newell J; McDermott AM; Keane MM; Lowery AJ; Miller N; Kerin MJ
Breast Cancer Res Treat; 2023 Nov; 202(1):73-81. PubMed ID: 37540289
[TBL] [Abstract][Full Text] [Related]
5. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention.
Sengupta D; Deb M; Kar S; Pradhan N; Parbin S; Kirtana R; Singh SP; Suma SG; Niharika ; Roy A; Manna S; Saha P; Chakraborty P; Dash S; Kausar C; Patra SK
Semin Cancer Biol; 2021 Jul; 72():46-64. PubMed ID: 32497683
[TBL] [Abstract][Full Text] [Related]
6. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in breast cancer.
Singh R; Mo YY
Cancer Biol Ther; 2013 Mar; 14(3):201-12. PubMed ID: 23291983
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
10. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Profiles and Breast Cancer Chemotherapy.
Davey MG; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639152
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
[TBL] [Abstract][Full Text] [Related]
14. microRNAs as mediators of drug toxicity.
Yokoi T; Nakajima M
Annu Rev Pharmacol Toxicol; 2013; 53():377-400. PubMed ID: 23189953
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
[TBL] [Abstract][Full Text] [Related]
17. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
18. Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
Esplugas R; Arenas M; Serra N; Bellés M; Bonet M; Gascón M; Vallvé JC; Linares V
PLoS One; 2019; 14(5):e0217443. PubMed ID: 31150454
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
Petrović N; Nakashidze I; Nedeljković M
J Mammary Gland Biol Neoplasia; 2021 Jun; 26(2):157-178. PubMed ID: 33479880
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as noninvasive biomarkers in breast cancer.
Cortez MA; Welsh JW; Calin GA
Recent Results Cancer Res; 2012; 195():151-61. PubMed ID: 22527502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
